AdvisorShares Pure Cannabis ETF

Charlotte's Web Holdings, Inc. released FY2026 Q1 earnings on May 13 (EST), actual revenue USD 11.16 M (forecast USD 13 M), actual EPS USD -0.08

Organigram released FY2026 Q2 earnings on May 12 Pre-Market (EST), actual revenue USD 42.92 M (forecast USD 49.41 M), actual EPS USD -0.005 (forecast USD -0.0035)

Cronos released FY2026 Q1 earnings on May 11 Pre-Market (EST), actual revenue USD 45.21 M (forecast USD 41.33 M), actual EPS USD 0.0365 (forecast USD 0.0051)

Village Farms released FY2026 Q1 earnings on May 11 Pre-Market (EST), actual revenue USD 50.24 M (forecast USD 47.81 M), actual EPS USD 0.02 (forecast USD 0.0233)

High Tide's Remexian Pharma Records 8 Tonns of Medical Cannabis Distribution

Organigram to release FY2026 Q2 earnings on May 12 Pre-Market EST, forecast revenue USD 50.75 M, EPS USD -0.011

Village Farms to Release FY2026 Q1 Earnings on May 11 Pre-Market (EST), Forecast Revenue USD 47.81 M, EPS USD 0.0233

Cronos to release FY2026 Q1 earnings on May 11 Pre-Market EST, forecast revenue USD 42.17 M, EPS USD 0.0051

SNDL released FY2026 Q1 earnings on April 29 Pre-Market EST, actual revenue USD 140.64 M (forecast USD 150.97 M), actual EPS USD -0.0287 (forecast USD -0.0323)

SNDL to release FY2026 Q1 earnings on April 29 Pre-Market EST, forecast revenue USD 154.31 M, EPS USD -0.033

Aurora Cannabis Acquires Safari Flower Company to Accelerate Global Medical Marijuana Leadership

Charlotte's Web Holdings, Inc. released FY2025 earnings on March 31 Pre-Market (EST), actual revenue USD 49.9 M (forecast USD 50.66 M), actual EPS USD -0.19

Charlotte's Web Holdings, Inc. released FY2025 Q4 earnings on March 31 Pre-Market (EST), actual revenue USD 13.33 M (forecast USD 17.42 M), actual EPS USD -0.0716

Charlotte's Web Holdings, Inc. to Release FY2025 Q4 Earnings on March 31 Pre-Market EST, Forecast Revenue USD 17.42 M

High Tide released FY2026 Q1 earnings on March 17 After-Market (EST), actual revenue USD 130.97 M (forecast USD 127.64 M), actual EPS USD 0.0073 (forecast USD 0.002)

High Tide Reports Q1 2026 Financials and Plans Expansion of Canna Cabana Stores

Frederico Gomes Maintains Buy Rating on SNDL

Village Farms released FY2025 Q4 earnings on March 12 Pre-Market EST, actual revenue USD 49.62 M (forecast USD 52.98 M), actual EPS USD 0.0123 (forecast USD 0.0433)

SNDL released FY2025 Q4 earnings on March 12 Pre-Market (EST), actual revenue USD 184.33 M (forecast USD 188.33 M), actual EPS USD 0.0246 (forecast USD 0.0109)

SNDL released FY2025 Annual Earnings on March 12 Pre-Market (EST), Actual Revenue: USD 681.73 M (Forecast: USD 694.89 M), Actual EPS: USD -0.044 (Forecast: USD -0.0584)

NextNRG

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Meiwu Tech

QUARTZSEA ACQUISITION CORP ORD USD0.0001 (18/02/2030) (S/R)

Generation Income Properties

CN Energy

MetaVia

YOLO

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

StockTitan

Aurora Cannabis

Amplify Alternative Harvest ETF

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

IIPR

Innovative Ind Props (NYSE:IIPR) reported Q1 2026 earnings, with total revenues of $69 million and AFFO of $53.4 million, maintaining the same AFFO per share as the previous quarter. The company raised $128 million through debt and equity and is pursuing an additional $130 million in financing. Significant leasing progress was made, with new leases for over 389,000 square feet. Management expressed optimism about growth in the cannabis and life science sectors, highlighting the regulatory shift of cannabis from Schedule 1 to 3 as a key development.

benzinga_article

Innovative Industrial Properties

INNOVATIVE INDUSTRIAL PROPERTES INC 9% CUM RED PFD STOCK SER A USD25

Full Transcript: Innovative Ind Props Q1 2026 Earnings Call

MSOS

WEED

CNBS

President Trump announced plans to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act, providing a boost to cannabis stocks that have faced significant losses over the past five years. This announcement follows an executive order aimed at increasing funding and research for psilocybin and other substances.

AdvisorShares Pure US Cannabis ETF

Roundhill Cannabis ETF

Amplify Seymour Cannabis ETF

Trump's rescheduling of marijuana is a spark for top marijuana ETFs

TLRY

Tilray Brands, a Canadian cannabis producer, is optimistic about entering the U.S. marijuana market following the U.S. government's rescheduling of medical marijuana to Schedule III. However, this rescheduling does not equate to legalization, and marijuana remains federally illegal in the U.S. Despite Tilray's claims of being positioned for U.S. expansion, significant government reform could take years. Investors have faced losses in cannabis stocks, and the outlook for Tilray remains uncertain, suggesting a cautious approach is advisable.

nasdaq

Tilray Brands

NVIDIA

Intel

Netflix

Nasdaq

S&P 500

NVIDIA Corporation

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

CURLF

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down from $3.52 to $3.28 before trading on Friday, with a last trade at $3.51. Analysts have raised the stock's rating from "strong sell" to "hold," with an average rating of "buy". The company reported a quarterly revenue of $333.07 million, beating estimates, but has a negative net margin of 18.08%. Curaleaf is a leading cannabis company operating across the U.S., managing its supply chain from cultivation to retail.

Market Beat

Curaleaf Holdings, Inc.

Curaleaf (OTCMKTS:CURLF) Shares Gap Down   - Time to Sell?

The cannabis sector is experiencing volatility driven by three key catalysts. Recent federal reforms have led to the rescheduling of medical cannabis, potentially injecting $2 billion into company balance sheets. However, a lawsuit from prohibitionists could create stock weakness. Additionally, the possibility of retroactive tax relief under IRS Rule 280E and a hearing on recreational cannabis rescheduling in mid-2026 could further impact the market. Investors should monitor these developments for potential entry and exit points.

CabotWealthNetwork

Green Thumb Industries Inc.

3 Catalysts Driving Cannabis Sector Volatility in 2026

MSOX

512690

TOKE

SNDL (NASDAQ:SNDL) reported a 4.4% year-over-year decline in net revenue to $196 million and a gross profit decrease of 6.8% to $53 million in its Q1 2026 earnings call. The decline was attributed to challenges in the liquor and cannabis markets, alongside working capital management issues. However, the company anticipates profitability improvements from initiatives aimed at generating over $20 million in incremental operating income this year. SNDL is optimistic about future growth, particularly in international sales, and is actively utilizing its share repurchase program due to perceived undervaluation of shares.

AdvisorShares MSOS 2x Daily ETF

Penghua CSI Alcoholic Drink ETF

Cambria Cannabis ETF

SNDL

Full Transcript: SNDL Q1 2026 Earnings Call

Tilray Brands Inc. (TLRY) shares rose 2.07% to $6.89 on Monday, outperforming a mixed stock market session. The NASDAQ Composite increased by 0.20%, while the Dow Jones fell by 0.13%. This rise ended a two-day losing streak for Tilray, although the stock remains 70.30% below its 52-week high of $23.20 reached on October 9th. Trading volume was 7.1 million, surpassing the 50-day average of 4.3 million.

MarketWatch Automated

NASDAQ Composite Index

Dow Jones Industrial Average

Factset Research

Tilray Brands Inc. Stock Rises Monday, Outperforms Market

Tilray Brands (NASDAQ:TLRY) shares fell 2.7% to $6.75 during trading, with a significant increase in volume. Positive sentiment surrounds the company due to federal rescheduling of cannabis, which may boost U.S. medical expansion. However, insider selling and dilution concerns have negatively impacted stock performance. Analysts have mixed ratings, with a consensus hold rating and an average price target of $11.50. The company reported a loss of $0.24 EPS, missing estimates, and has a negative net margin of 156.51%.

Tilray Brands (NASDAQ:TLRY) Trading Down 2.7%  - Here's Why

Shares in cannabis companies fell after the U.S. reclassified marijuana from Schedule I to Schedule III, which Roth Capital views as "extremely favorable". The DOJ's decision allows cannabis companies with state medical licenses to deduct normal business expenses, easing tax burdens. Despite initial stock surges, major companies like Tilray and Canopy Growth saw declines. Roth Capital highlights potential benefits, including international commerce and future rescheduling for adult use. Aurora Cannabis (ACB) is noted as a strong buy with a 105% upside based on analyst ratings.

Tip Ranks

Canopy Growth

Cronos

Is U.S. Marijuana Reclassification 'Extremely Favorable' for Cannabis Stocks?

AdvisorShares Pure Cannabis ETF(YOLO.US)

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

Full Transcript: Innovative Ind Props Q1 2026 Earnings Call

Trump's rescheduling of marijuana is a spark for top marijuana ETFs

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - Time to Sell?